UPADACITINIB Pharmacologic Class Indexing
- Class set ID
- 7269c7df-6bd0-4baf-af74-e796ae4e6a1b
- Version
- 1
- Effective date
- 20230705
- Type
- Indexing - Pharmacologic Class
Mapped DailyMed Labels#
| Label | Manufacturer | Effective | SPL version |
|---|---|---|---|
| These highlights do not include all the information needed to use RINVOQ / RINVOQ LQ safely and effectively. See full prescribing information for RINVOQ / RINVOQ LQ . RINVOQ ® (upadacitinib) extended-release tablets, for oral use RINVOQ ® LQ (upadacitinib) oral solution Initial U.S. Approval: 2019 | AbbVie Inc. | 20251023 | 100 |